News from spark therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:SCHS)

Jun 16, 2014, 08:30 ET

Spark Therapeutics Appoints Industry Leaders Lars Ekman and Vin Milano to Board of Directors

 Spark Therapeutics, a late-stage gene therapy company developing treatments for a wide range of rare, debilitating diseases, announced today...

Jun 02, 2014, 14:34 ET

Spark Therapeutics Leadership to Present at Three Upcoming Healthcare Investor Conferences

 Spark Therapeutics, Inc., a late-stage gene therapy company developing treatments for a wide range of rare, debilitating diseases, announced...

May 27, 2014, 14:47 ET

Spark Therapeutics Raises $72.8 Million in Oversubscribed Financing

 Spark Therapeutics, a late-stage company developing gene-based medicines for a wide range of rare, debilitating diseases, today announced the...

May 19, 2014, 11:24 ET

Spark Therapeutics to Present at the American Society of Gene & Cell Therapy 2014 Annual Meeting

Spark Therapeutics, a late-stage company developing gene-based medicines for a wide range of debilitating diseases, announced today that co-founder...

May 13, 2014, 09:08 ET

Spark Therapeutics Establishes Permanent Headquarters in West Philadelphia

 Spark Therapeutics, a late-stage company developing gene-based medicines for a wide range of debilitating diseases, announced today that it...

Mar 25, 2014, 00:00 ET

Spark Therapeutics and Genable Technologies Announce Collaboration to Advance a Gene Therapy Treatment for a Rare Form of Retinitis Pigmentosa

Spark Therapeutics and Genable Technologies announced today that they have entered into a collaboration agreement for Genable's lead therapeutic to...

Feb 11, 2014, 08:15 ET

Spark Therapeutics Appoints Industry Leader Dr. Elliott Sigal, Former Executive Vice President and Chief Scientific Officer of Bristol-Myers Squibb, to Board of Directors

 Spark Therapeutics, a late-stage company developing gene-based medicines for a wide range of debilitating diseases, announced today the...

Jan 21, 2014, 08:30 ET

Spark Therapeutics Names Dr. Rogerio Vivaldi to Board of Directors

Spark Therapeutics, a late-stage company developing gene-based medicines for a wide range of debilitating diseases, announced today that it...

Jan 14, 2014, 10:07 ET

Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness

Spark Therapeutics, a late-stage gene therapy company, has reached its patient recruitment goal for its most advanced clinical program, a...

Jan 09, 2014, 09:09 ET

Spark Therapeutics Expands Leadership Team to Support Development and Commercialization of its Late-Stage Gene Therapy Pipeline

 Spark Therapeutics, a late-stage, fully integrated company developing gene-based medicines for a wide range of debilitating diseases,...

Dec 20, 2013, 08:30 ET

Spark Therapeutics to Present at 32nd Annual J.P. Morgan Healthcare Conference

 Spark Therapeutics, a fully integrated, late-stage gene therapy company, announced today that President and Chief Executive Officer Jeffrey D....

Dec 09, 2013, 09:00 ET

ASH 2013: Spark Therapeutics Co-Founder and Gene Therapy Pioneer Dr. Katherine A. High Outlines Challenges and Promises for Gene Therapy

 Spark Therapeutics, a fully integrated, late-stage gene therapy company, today announced that its co-founder and scientific advisor, Dr....

Oct 22, 2013, 08:00 ET

Spark Therapeutics Launched with $50 Million in Financing to Advance Late- and Mid-Stage Gene Therapy Programs with Clinical Proof of Concept

 Spark Therapeutics, a new, fully integrated company developing gene-based medicines for a wide range of debilitating diseases, announced today...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge